• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

US House panel to hold hearing with pharmacy benefit managers on healthcare costs

cafead

Administrator
Staff member
  • cafead   Jul 16, 2024 at 11:22: PM
via The U.S. House of Representatives oversight panel said on Tuesday it will hold a hearing with executives from U.S. pharmacy benefit managers on the role of the firms in rising healthcare costs.

article source